Brennan, Melanie S.

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 3,059

Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro

Brennan, M. S., Matos, M. F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K. J., & Scannevin, R. H. (2015) · PLOS ONE

Genomics, phytochemicals, and oxidative stressGlutathione Transferases and Polymorphisms

Cited by 188

The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes

Brennan, M. S., Matos, M. F., Richter, K. E., Li, B., & Scannevin, R. H. (2017) · Scientific Reports

Genomics, phytochemicals, and oxidative stressEndoplasmic Reticulum Stress and Disease

Cited by 87

Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2017) · Nature

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 83